Catalyst Wire Dossier Catalyst Wire Dossier

Orbactiv

oritavancin
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Orbactiv, covering 2014-08-06 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Oritavancin for CIED Infections With MDR Gram-positive Cocci [NA]

See pricing